Preclin Biosystems


	Models Infectious disease Autoimmune diseases Lung diseases Intestinal diseases Preclin Biosystems’ approach

Preclin Biosystems AG Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.
	Our extensive range of chronic inflammatory and infectious disease models are run routinely in our core facility providing a ‘one stop shop’ for preclinical drug efficacy testing. Our parallel testing approach for in vivo assessment of lead candidates can provide an overall efficacy, side effect and target market analysis condensing the preclinical phase of drug development dramatically. For more information on our service and partnership opportunities contact: info@preclinbiosystems.com

News

November 2012: Meet Preclin Biosystems AG at the Bio-Europe 2012 in Hamburg (12-14 November). To schedule a meeting contact:
info@preclinbiosystems.com

September 2012: Meet Preclin Biosystems AG at the BioPharm America conference in Boston (19-21 September). To schedule a meeting contact:
info@preclinbiosystems.com

June 2012: Meet Preclin Biosystems AG at the Bio International Convention 2012 in Boston (18-21 June). To schedule a meeting contact:
info@preclinbiosystems.com

March 2012:Meet Preclin Biosystems AG at the Bio-Europe Spring 2012 conference in Amsterdam (19-21 March). To schedule a meeting contact:
info@preclinbiosystems.com

February 2012: Meet Preclin Biosystems AG at the 6th Swiss-Scandinavian Bio-Business Seminar in Zurich (8 February). To schedule a meeting contact:
info@preclinbiosystems.com

February 2012: Meet Preclin Biosystems AG at the BioBusiness 2012 conference in London (1-2 February). To schedule a meeting contact:
info@preclinbiosystems.com

November/ December 2011: Meet Preclin Biosystems AG at the Outsourcing Preclinical Development conference in Zurich (30 November – 1 December). To schedule a meeting contact:
info@preclinbiosystems.com

info@preclinbiosystems.com